NOVO NORDISK A S TRADE DATA ANALYSIS
Access comprehensive trade data for Novo Nordisk A S with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Novo Nordisk A S – Overview
Eximpedia analyzes Novo Nordisk A S export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of Novo Nordisk A S that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Novo Nordisk A S Buyers, Suppliers & Shipments
Novo Nordisk A S import markets
Explore the Novo Nordisk A S import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004310000 | 14.41 | 61 | 53.51 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004390000 | 2.48 | 8 | 7.02 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3002150000 | 0.40 | 7 | 6.14 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3006930000 | 0.15 | 16 | 14.04 |
| PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER | |||
| 3004900000 | 0.07 | 12 | 10.53 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| DENMARK | 7.40 | 56 | 49.12 |
| BRAZIL | 5.51 | 29 | 25.44 |
| UNITED STATES | 2.31 | 2 | 1.75 |
| FRANCE | 2.24 | 16 | 14.04 |
| GERMANY | 0.05 | 4 | 3.51 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 16.97 | 76 | 66.67 |
| UA100330 | 0.58 | 38 | 33.33 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| SWIXX BIOPHARMA LLP SWIXX BIOPHARMA | 28.01 | 198 |
| NOVO NORDISK LLC | 28.03 | 281 |
| TOV NOVO NORDISK UKRAINE | 39.84 | 107 |
| SANOFI AVENTIS DE COLOMBIA SA | 47.03 | 292 |
| SANOFI HEALTH PRODUCTS LIMITED COMPANY | 101.76 | 4052 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| NOVO NORDISK A S | 28.03 | 2093 |
| SWIXX BIOPHARMA AG | 28.71 | 343 |
| NOVO NORDISK A S | 28.81 | 2093 |
| SANOFI AVENTIS DE PANAMA S A | 75.96 | 1464 |
| SANOFI WINTROP INDUSTRIES | 101.76 | 347 |
If you are looking to establish relationship with Novo Nordisk A S Automation you can save time by getting access to the key decision makers and get a detailed report.
Novo Nordisk A S Import Shipments
Discover the Novo Nordisk A S with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3006930000 | 1. MEDICINAL PRODUCTS ARE UNREGISTERED, (NOT IN AEROSOL PACKAGING) FOR HUMANS, INTENDED FOR BLIND (DOUBLE-BLIND) CLINICAL TRIALS ACCORDING TO THE EX6018-4758 PROTOCOL, PACKAGED IN DOSAGE FORMS, NOT FOR RETAIL SALE, DO NOT CONTAIN NARCOTIC AND PSYCHOTROPIC SUBSTANCES:- ZILTIVEKIMAB C 30 MG/ML OR PLACEBO, SOLUTION FOR INJECTION IN A PRE-FILLED DISPOSABLE SYRINGE PEN 0.5 ML #2 - 224 SETS. PACKAGING SERIES: TO23/1048. MANUFACTURER SERIES NX52021, NX51952. EXPIRY DATE: 03/05/2025. MANUFACTURER: NOVO NORDISK A/S. TRADEMARK - NOVO NORDISK. COUNTRY OF MANUFACTURE DK. |  |
|
DENMARK | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS ARE UNREGISTERED, (NOT IN AEROSOL PACKAGING) FOR HUMANS, INTENDED FOR BLIND (DOUBLE-BLIND) CLINICAL TRIALS ACCORDING TO THE EX6018-4758 PROTOCOL, PACKAGED IN DOSAGE FORMS, NOT FOR RETAIL SALE, DO NOT CONTAIN NARCOTIC AND PSYCHOTROPIC SUBSTANCES:- ZILTIVEKIMAB B 15 MG/ML OR PLACEBO, SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1 ML NO. 1 - 90 PCS. PACKAGING SERIES: TO23/0593. MANUFACTURER'S SERIES COUJ02, COVI06. EXPIRY DATE: 10/13/2024. MANUFACTURER: NOVO NORDISK A/S. TRADEMARK - NOVO NORDISK. COUNTRY OF MANUFACTURE DK. | |
|
DENMARK | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: LEVEMIR« FLEXPEN«, SOLUTION FOR INJECTION, 100 UNITS/ML OF 3 ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE SYRINGE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES MR7EE29 - 2160 UNITS. (ACTIVE SUBSTANCES: 1 ML OF SOLUTION FOR INJECTION CONTAINS 100 UNITS (14.2 MG) OF INSULIN DETEMIR (RDNA); 1 PRE-FILLED SYRINGE PEN CONTAINS 3 ML, WHICH IS EQUIVALENT TO 300 UNITS; 1 UNIT (U) OF INSULIN DETEMIR CORRESPONDS TO 1 MO OF HUMAN INSULIN) TRADE MARK: LEVEMIR, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (MANUFACTURER OF BULK PRODUCTS, FILLING IN PENFIL«, PRIMARY PACKAGING AND ASSEMBLY, MARKING AND PACKAGING OF FLEXPEN«, SECONDARY PACKAGING) | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINAL PRODUCTS FOR HUMAN THERAPEUTIC USE CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: NOVORAPID« FLEXPEN«, SOLUTION FOR INJECTION, 100 UNITS/ML OF 3 ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN, 5 SYRINGE-PEN IN A CARDBOARD BOX SERIES NR7LE84 - 4806 UNITS. (ACTIVE SUBSTANCES - 1 ML OF SOLUTION CONTAINS 100 UNITS (100 UNITS CORRESPONDS TO 600 NMOL) OF INSULIN ASPART (RDNA), WHICH IS EQUIVALENT TO 3.5 MG) TRADE MARK: NOVORAPID, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (MANUFACTURER OF BULK PRODUCTS, PRIMARY AND SECONDARY PACKAGING) | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: ACTRAPID« NM FLEXPEN«, SOLUTION FOR INJECTION, 100 IU/ML; 3 ML EACH IN A CARTRIDGE; 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES NR7MH79 - 8640 UNITS (1 ML OF INJECTION SOLUTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN;1 MULTI-DOSE DISPOSABLE SYRINGE-PEN CONTAINS 3 ML OF SOLUTION FOR INJECTION, WHICH IS EQUIVALENT TO 300 IU) TRADE MARK: AKTRAPID, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (MANUFACTURER OF UNPACKAGED PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL« CARTRIDGES); ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN«); QUALITY CONTROL OF THE FINISHED PRODUCT (FLEXPEN«) | |
|
BRAZIL | UKRAINE | 0 |
| 9018321000 | 1. MEDICAL PRODUCTS: SINGLE-USE NEEDLES, STERILE, TUBULAR, METAL, PACKAGED FOR RETAIL SALE FOR USE WITH SYRINGE PENS NOVOFINE® 30G X 8MM, NO. 100 SERIES MS7F18X-1 - 410 UNITS. TRADE MARK: NOVOFINECOUNTRY OF MANUFACTURE: JPMANUFACTURER: NOVO NORDISK A/ S""" | |
|
JAPAN | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: ACTRAPID® NM FLEXPEN®, SOLUTION FOR INJECTION, 100 IU/ML; 3 ML EACH IN A CARTRIDGE; 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES NR7MH80 - 6480 UNITS (1 ML OF INJECTION SOLUTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN; 1 MULTI-DOSE DISPOSABLE SYRINGE-PEN CONTAINS 3 ML OF SOLUTION FOR INJECTION, WHICH IS EQUIVALENT TO 300 IU) TRADE MARK: AKTRAPID, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (PRODUCER OF UNPACKAGED PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL® CARTRIDGES); ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN®); QUALITY CONTROL OF THE FINISHED PRODUCT (FLEXPEN®)""" | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: PROTAFAN® NM FLEXPEN®, SUSPENSION FOR INJECTION, 100 IU/ML, 3 ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN, 5 SYRINGES - PEN IN A CARDBOARD BOX MR7EV24 - 54 UNITS, SERIES MR7EV25 - 54 UNITS (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN ; 1 MULTI-DOSE DISPOSABLE PEN CONTAINS 3 ML OF SUSPENSION FOR INJECTION, WHICH IS EQUIVALENT TO 300 IU; PROTAFAN® NM FLEXPEN® IS AN ISOPHANE (NPH) INSULIN SUSPENSION) TRADE MARK: PROTAFAN, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRAZIL LTD. (MANUFACTURER OF BULK PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL® CARTRIDGES); ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN®); QUALITY CONTROL OF THE FINISHED PRODUCT (FLEXPEN®))""" | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINAL PRODUCTS FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: TRESIBA® FLEXTACH®, SOLUTION FOR INJECTION, 100 U/ML, 3 ML IN A CARTRIDGE CONTAINED IN A MULTI-DOSE DISPOSABLE PEN, 5 SYRINGES PEN IN A CARDBOARD BOX SERIES NP5F717 - 3024 UNITS, SERIES NP5H844 - 3072 UNITS (ACTIVE SUBSTANCES: 1 ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC (EQUIVALENT TO 3.66 MG OF INSULIN DEGLUDEC), 1 PRE-FILLED SYRINGE PEN CONTAINS 3 ML OF SOLUTION, WHICH IS EQUIVALENT TO 300 UNITS OF INSULIN DEGLUDEC) TRADE MARK: TRESIBA, FLEXSTACH COUNTRY OF MANUFACTURE: DK MANUFACTURER: A/T NOVO NORDISK (PRODUCTION, FILLING IN PRIMARY PACKAGING AND CONTROL OF THE BEAM; ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT; QUALITY CONTROL OF THE BEAM OF THE FINISHED PRODUCT AND THE FINAL FINISHED PRODUCT; RESPONSIBLE FOR ISSUING)""" | |
|
DENMARK | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: PROTAFAN« NM FLEXPEN«, SUSPENSION FOR INJECTION, 100 IU/ML; 3 ML EACH IN A CARTRIDGE; 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES NR7MJ19 - 4320 UNITS (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN; 1 MULTIDOSE DISPOSABLE PEN CONTAINS 3 ML OF SUSPENSION FOR INJECTION, EQUIVALENT TO 300 IU; PROTAFAN« NM FLEXPEN« IS AN ISOPHANE (NPH) INSULIN SUSPENSION)TRADEMARK: PROTAFAN, FLEXPENCOUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA . (MANUFACTURER OF UNPACKAGED PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL« CARTRIDGES); ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN«); QUALITY CONTROL OF THE FINISHED PRODUCT (FLEXP | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: LEVEMIR« FLEXPEN«, SOLUTION FOR INJECTION, 100 UNITS/ML OF 3 ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE SYRINGE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES MR7GV50 - 2430 UNITS. (ACTIVE SUBSTANCES: 1 ML OF SOLUTION FOR INJECTION CONTAINS 100 UNITS (14.2 MG) OF INSULIN DETEMIR (RDNA); 1 PRE-FILLED SYRINGE PEN CONTAINS 3 ML, WHICH IS EQUIVALENT TO 300 UNITS; 1 UNIT (U) OF INSULIN DETEMIR CORRESPONDS TO 1 MO OF HUMAN INSULIN) TRADE MARK: LEVEMIR, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (MANUFACTURER OF BULK PRODUCTS, FILLING IN PENFIL«, PRIMARY PACKAGING AND ASSEMBLY, MARKING AND PACKAGING OF FLEXPEN«, SECONDARY PACKAGING) | |
|
BRAZIL | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS NOT REGISTERED, (NOT IN AN AEROSOL PACKAGE) FOR HUMANS, INTENDED FOR CLINICAL TRIALS ACCORDING TO THE PROTOCOL NN8640-4245 IN A DOSED FORM, NOT FOR RETAIL TRADE, NOT OF ANIMAL ORIGIN.- SOMAPACITAN SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE PEN PDS290 WITH A VOLUME OF 15 MG/1.5 ML (10 MG/ML) - 30 PCS. PACKAGING SERIES: MC76324. MANUFACTURER'S SERIAL B000207647. EXPIRY DATE: NOVEMBER 25, 2024. MANUFACTURER: NOVO NORDISK A/S. TRADEMARK - NOVO NORDISK. COUNTRY OF MANUFACTURE DK. | |
|
DENMARK | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS NOT REGISTERED, CONTAINING HORMONES (NOT IN AN AEROSOL PACKAGE), FOR HUMANS, INTENDED FOR BLIND (DOUBLE-BLIND) CLINICAL TRIALS ACCORDING TO THE PROTOCOL NN6535-4725, PACKAGED IN THE FORM OF DOSAGE FORMS, NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN.- SEMAGLUTIDE 7 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 40 UNITS; PACKAGING SERIES: TO23/0839. MANUFACTURER SERIES ME75067, ME75106. EXPIRY DATE: 10/24/2024 - SEMAGLUTIDE 3 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 60 UNITS; PACKAGING SERIES: TO23/0761. MANUFACTURER SERIES ME75067, NE75402. EXPIRY DATE: 07/04/2024 - SEMAGLUTIDE 14 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 85 UNITS; PACKAGING SERIES: TO23/0678. MANUFACTURER SERIES ME74485, ME74797. EXPIRY DATE: 13/06/2024; MANUFACTURER: NOVO NORDISK A/S. TRADEMARK: NOVO NORDISK. COUNTRY OF MANUFACTURE DK. | |
|
DENMARK | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS NOT REGISTERED, (NOT IN AEROSOL PACKAGING), FOR HUMANS, INTENDED FOR BLIND (DOUBLE-BLIND) CLINICAL TRIALS ACCORDING TO THE PROTOCOL EX9924-4473, PACKAGED IN THE FORM OF DOSAGE FORMS, NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN:- SEMAGLUTIDE 14 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 738 UNITS; PACKAGING SERIES: TO23/0735. MANUFACTURER SERIES ME75064, ME75109. EXPIRY DATE: 18.10.2025; - SEMAGLUTIDE 3 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 2 UNITS; PACKAGING SERIES: TO23/0469. MANUFACTURER SERIES ME74789, ME75064. EXPIRY DATE: 09/06/2025 - SEMAGLUTIDE 7 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 250 UNITS; PACKAGING SERIES: TO23/0010. MANUFACTURER SERIES LE72894A, ME74794. EXPIRY DATE: 06/03/2024; - SEMAGLUTIDE 14 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 750 UNITS; PACKAGING SERIES: TO23/0791. MANUFACTURER SERIES ME | |
|
DENMARK | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS NOT REGISTERED, (NOT IN AEROSOL PACKAGING) FOR HUMANS, KIT FOR CONDUCTING BLIND (DOUBLE-BLIND) CLINICAL TRIALS ACCORDING TO THE PROTOCOL NN9535-4321 NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN.- SEMAGLUTIDE 1.34 MG/ML OR PLACEBO, SOLUTION FOR OF INJECTIONS IN A PRE-FILLED SYRINGE PEN PDS290 OF 1.5 ML NO. 2 - 290 PCS.; PACKAGING SERIES: TO23/0636. MANUFACTURER SERIES MP5C932, NP5F4666. EXPIRY DATE: 05/25/2025. MANUFACTURER: NOVO NORDISK A/S. TRADEMARK: NOVO NORDISK. COUNTRY OF MANUFACTURE DK. | |
|
DENMARK | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS CONTAINING HORMONES (NOT AEROSOLIZED), FOR HUMANS, INTENDED FOR BLIND (DOUBLE-BLIND) CLINICAL TRIALS UNDER PROTOCOL NN6535-4730 IN THE FORM OF DOSAGE FORMS, NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN:- SEMAGLUTIDE 7 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 23 UNITS; PACKAGING SERIES: TO23/0825. MANUFACTURER SERIES ME74797, ME75106. EXPIRY DATE: 10/24/2024 - SEMAGLUTIDE 3 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 40 UNITS; PACKAGING SERIES: TO23/0794. MANUFACTURER SERIES ME75067, NE75402. EXPIRY DATE: 07/04/2024 - SEMAGLUTIDE 14 MG OR PLACEBO, TABLETS FOR ORAL USE, 7 TABLETS IN A PACK. - 45 UNITS; PACKAGING SERIES: TO22/0932. MANUFACTURER SERIES ME75064, ME75112. EXPIRY DATE: 10/20/2024. MANUFACTURER: NOVO NORDISK A/S. TRADEMARK: NOVO NORDISK. COUNTRY OF MANUFACTURE DK. | |
|
DENMARK | UKRAINE | 0 |
| 9018321000 | 1. RELATED MATERIALS FOR CONDUCTING MULTICENTER CLINICAL TRIALS, ACCORDING TO PROTOCOL NN7415-4307. TUBULAR METAL NEEDLES: DISPOSABLE NEEDLES, STERILE FOR USE WITH SYRINGE PENS, NOVOFINE(R) PLUS 32G 4MM (100 PCS IN A PACKAGE) - 20 PACKS; MANUFACTURER: NOVO NORDISK A/S. TRADEMARK: NOVOFINE. COUNTRY OF MANUFACTURE: DK. | |
|
DENMARK | UKRAINE | 0 |
| 9018321000 | 1. RELATED MATERIALS FOR CONDUCTING MULTICENTER CLINICAL TRIALS, ACCORDING TO PROTOCOL NN7415-4311. TUBULAR METAL NEEDLES: DISPOSABLE NEEDLES, STERILE FOR USE WITH SYRINGE PENS, NOVOFINE PLUS 32G 4MM (100 PCS IN A PACKAGE) - 20 PACKS; MANUFACTURER: NOVO NORDISK A/S. TRADEMARK: NOVOFINE. COUNTRY OF MANUFACTURE: DK. | |
|
DENMARK | UKRAINE | 0 |
| 3004390000 | 1. MEDICINES FOR HUMANS CONTAINING HORMONES AS PACKAGED FOR RETAIL: VICTOZA® SOLUTION FOR INJECTION, 6MG/ML, 3ML CARTRIDGES IN A PRE-FILLED MULTI-DOSE DISPOSABLE SYRINGE; 2 PRE-FILLED SYRINGES-PENS IN A CARDBOARD BOX SERIES NS6JK01 - 1977UP. (1 ML OF SOLUTION CONTAINS 6 MG OF LIRAGLUTIDE - AN ANALOGUE OF HUMAN GLUCAGON-LIKE PEPTIDE-1 (GPP-1) MANUFACTURED USING RECOMB TECHNOLOGY INSTANT DNA IN SACCHAROMYCES CEREVISIAE ONE PRE-FILLED SYRINGE -PEN CONTAINS 18 MG LIRAGLUTIDE IN 3 ML) TRADE BRAND: VICTOZA COUNTRY OF MANUFACTURE: DK MANUFACTURER: A/T NOVO NORDISK (MANUFACTURER, UNPACKAGED PRODUCT, FILLING, PRIMARY PACKAGING, QUALITY CONTROL AND RESPONSIBLE FOR ISSUING SE END PRODUCT HIVE; MANUFACTURER TO COLLECT, LABELING AND PACKAGING, SECONDARY PACKAGING) | |
|
DENMARK | UKRAINE | 0 |
| 3004390000 | 1. DRUGS FOR HUMANS CONTAINING HORMONES AS PACKAGED FOR RETAIL: SAXENDA® SOLUTION FOR INJECTION, 6MG/ML; 3ML EACH IN CARTRIDGES INSTALLED IN A PRE-FILLED MULTI-DOSE DISPOSABLE SYRINGE PEN; 3 PRE-FILLED SYRINGES-PENS IN A CARDBOARD BOX SERIES NP5K155 - 3500 UNITS (1ML OF SOLUTION CONTAINS 6MG LIRAGLUTIDE - AN ANALOGUE OF HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1), MANUFACTURED USING RECOMBINANT TECHNOLOGY DNA IN SACCHAROMYCES CEREVISIAE; ONE PRE-FILLED SYRINGE CONTAINS 18MG LIRAGLUTIDE IN 3ML) TRADEMARK: SAXENDAKRAIN MANUFACTURER: DKMANUFACTURER: A/T NOVO NORDISK (ASSEMBLING, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT. BATCH CERTIFICATION; PRODUCT MANUFACTURING, CARTRIDGE FILLING INSPECTION AND QUALITY CONTROL OF IN BULK PRODUCTS. BATCH RELEASE AND CERTIFICATION) | |
|
DENMARK | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Novo Nordisk A S frequently asked questions
You can explore detailed shipment records of Novo Nordisk A S through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Novo Nordisk A S. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Novo Nordisk A S, helping you expand your sourcing network.
Eximpedia’s trade data highlights Novo Nordisk A S’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Novo Nordisk A S’s trade activities.
Traders can collaborate with Novo Nordisk A S by contacting them through their official channels or visiting their headquarters for detailed trade discussions.